Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10911-10921

  Demberg, Thorsten ^a   Boyer, Jean D ^b   Malkevich, Nina ^a   Patterson, L Jean ^a   Venzon, David ^a   Summers, Ebonita L ^a   Kalisz, Irene ^c   Kalyanaraman, V S ^c   Eun, Mi Lee ^c   Weiner, David B ^b   Robert Guroff, Marjorie ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CYTOKINE; DNA VACCINE; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 140; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; NEF PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN; IMMUNOLOGICAL ADJUVANT; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG RESPONSE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MACACA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS REPLICATION; ADENOVIRUS; ANIMAL; GENETICS; IMMUNOLOGY; MONKEY DISEASE; MONONUCLEAR CELL; PLASMID; VIREMIA;

ADENOVIRIDAE; MACACA; MACACA MULATTA; POXVIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS;

ADENOVIRIDAE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; IMMUNIZATION, SECONDARY; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; PLASMIDS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, DNA; VACCINES, SUBUNIT; VIRAL LOAD; VIREMIA;

EID: 55249117992     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01129-08     Document Type: Article

References (65)

1. Ahlers, J. D., I. M. Belyakov, and J. A. Berzofsky. 2003. Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines. Curr. Mol. Med. 3:285-301.
2. Airoldi, I., G. Gri, J. D. Marshall, A. Corcione, P. Facchetti, R. Guglielmino, G. Trinchieri, and V. Pistoia. 2000. Expression and function of IL-12 and IL-18 receptors on human tonsillar B cells. J. Immunol. 165:6880-6888.
3. Amara, R. R., F. Villinger, J. D. Altman, S. L. Lydy, S. P. O'Neil, S. I. Staprans, D. C. Montefiori, Y. Xu, J. G. Herndon, L. S. Wyatt, M. A. Candido, N. L. Kozyr, P. L. Earl, J. M. Smith, H. L. Ma, B. D. Grimm, M. L. Hulsey, J. Miller, H. M. McClure, J. M. McNicholl, B. Moss, and H. L. Robinson. 2001. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69-74.
4. Anderson, E. J., M. A. McGrath, T. Thalhamer, and I. B. McInnes. 2006. Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting. Springer Semin. Immunopathol. 27:425-442.
5. Baba, T. W., V. Liska, R. Hofmann-Lehmann, J. Vlasak, W. Xu, S. Ayehunie, L. A. Cavacini, M. R. Posner, H. Katinger, G. Stiegler, B. J. Bernacky, T. A. Rizvi, R. Schmidt, L. R. Hill, M. E. Keeling, Y. Lu, J. E. Wright, T. C. Chou, and R. M. Ruprecht. 2000. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:200-206.
6. Bergamaschi, C., M. Rosati, R. Jalah, A. Valentin, V. Kulkarni, C. Alicea, G. M. Zhang, V. Patel, B. K. Felber, and G. N. Pavlakis. 2008. Intracellular interaction of interleukin-15 with its receptor α during production leads to mutual stabilization and increased bioactivity. J. Biol. Chem. 283:4189-4199.
7. Boyer, J. D., T. M. Robinson, M. A. Kutzler, R. Parkinson, S. A. Calarota, M. K. Sidhu, K. Muthumani, M. Lewis, G. Pavlakis, B. Felber, and D. Weiner. 2005. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. J. Med. Primatol. 34:262-270.
8. Boyer, J. D., T. M. Robinson, M. A. Kutzler, G. Vansant, D. A. Hokey, S. Kumar, R. Parkinson, L. Wu, M. K. Sidhu, G. N. Pavlakis, B. K. Felber, C. Brown, P. Silvera, M. G. Lewis, J. Monforte, T. A. Waldmann, J. Eldridge, and D. B. Weiner. 2007. Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc. Natl. Acad. Sci. USA 104:18648-18653.
9. Boyer, J. D., T. M. Robinson, P. C. Maciag, X. Peng, R. S. Johnson, G. Pavlakis, M. G. Lewis, A. Shen, R. Siliciano, C. R. Brown, D. B. Weiner, and Y. Paterson. 2005. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology 333:88-101.
10. Cheng, S. M., S. G. Lee, M. Ronchetti-Blume, K. P. Virk, S. Mizutani, J. W. Eichberg, A. Davis, P. P. Hung, V. M. Hirsch, R. M. Chanock, R. H. Purcell, and P. R. Johnson. 1992. Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant. J. Virol. 66:6721-6727.
11. 89.6P challenge in rhesus macaques. Vaccine 25:4967-4982.
12. Demberg, T., R. H. Florese, M. J. Heath, K. Larsen, I. Kalisz, V. S. Kalyanaraman, E. M. Lee, R. Pal, D. Venzon, R. Grant, L. J. Patterson, B. Korioth-Schmitz, A. Buzby, D. Dombagoda, D. C. Montefiori, N. L. Letvin, A. Cafaro, B. Ensoli, and M. Robert-Guroff. 2007. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J. Virol. 81:3414-3427.
13. Egan, M. A., S. Y. Chong, S. Megati, D. C. Montefiori, N. F. Rose, J. D. Boyer, M. K. Sidhu, J. Quiroz, M. Rosati, E. B. Schadeck, G. N. Pavlakis, D. B. Weiner, J. K. Rose, Z. R. Israel, S. A. Udem, and J. H. Eldridge. 2005. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res. Hum. Retrovir. 21:629-643.
14. Fuller, D. H., P. A. Rajakumar, L. A. Wilson, A. M. Trichel, J. T. Fuller, T. Shipley, M. S. Wu, K. Weis, C. R. Rinaldo, J. R. Haynes, and M. Murphey-Corb. 2002. Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine. J. Virol. 76:3309-3317.
15. + T cells. J. Exp. Med. 194:1711-1719.
16. Gomez-Roman, V. R., R. H. Florese, L. J. Patterson, B. Peng, D. Venzon, K. Aldrich, and M. Robert-Guroff. 2006. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J. Immunol. Methods 308:53-67.
17. mac251. J. Immunol. 174:2185-2189.
18. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri. 1994. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264:965-968.
19. Hirao, L. A., L. Wu, A. S. Khan, D. A. Hokey, J. Yan, A. Dai, M. R. Betts, R. Draghia-Akli, and D. B. Weiner. 2008. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 26:3112-3120.
20. Hokey, D. A., and D. B. Weiner. 2006. DNA vaccines for HIV: challenges and opportunities. Springer Semin. Immunopathol. 28:267-279.
21. mac239. J. Virol. 76:7187-7202.
22. Hryniewicz, A., D. A. Price, M. Moniuszko, A. Boasso, Y. Edghill-Spano, S. M. West, D. Venzon, M. Vaccari, W. P. Tsai, E. Tryniszewska, J. Nacsa, F. Villinger, A. A. Ansari, C. J. Trindade, M. Morre, D. Brooks, P. Arlen, H. J. Brown, C. M. Kitchen, J. A. Zack, D. C. Douek, G. M. Shearer, M. G. Lewis, R. A. Koup, and G. Franchini. 2007. Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J. Immunol. 178:3492-3504.
23. + T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998.
24. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816-826.
25. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
26. c-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol. Rev. 202:67-83.
27. Liniger, M., A. Zuniga, and H. Y. Naim. 2007. Use of viral vectors for the development of vaccines. Expert Rev. Vaccines 6:255-266.
28. Loffredo, J. T., J. Maxwell, Y. Qi, C. E. Glidden, G. J. Borchardt, T. Soma, A. T. Bean, D. R. Beal, N. A. Wilson, W. M. Rehrauer, J. D. Lifson, M. Carrington, and D. I. Watkins. 2007. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J. Virol. 81:8827-8832.
29. Luckay, A., M. K. Sidhu, R. Kjeken, S. Megati, S. Y. Chong, V. Roopchand, D. Garcia-Hand, R. Abdullah, R. Braun, D. C. Montefiori, M. Rosati, B. K. Felber, G. N. Pavlakis, I. Mathiesen, Z. R. Israel, J. H. Eldridge, and M. A. Egan. 2007. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J. Virol. 81:5257-5269.
30. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24:657-679.
31. Malkevitch, N., L. J. Patterson, K. Aldrich, E. Richardson, W. G. Alvord, and M. Robert-Guroff. 2003. A replication competent Ad5hr-SIV recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in mamu-A*01 rhesus macaques. J. Immunol. 170:4281-4289.
32. + T cell responses. Virology 353:83-98.
33. Malkevitch, N. V., and M. Robert-Guroff. 2004. A call for replicating vector prime-protein boost strategies in HIV vaccine design. Expert Rev. Vaccines 3:S105-S117.
34. Malkevitch, N., D. Rohne, J. Pinczewski, K. Aldrich, V. S. Kalyanaraman, N. L. Letvin, and M. Robert-Guroff. 2004. Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques. AIDS Res. Hum. Retrovir. 20:235-244.
35. + lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype. J. Virol. 79:14887-14898.
36. Mascola, J. R., M. G. Lewis, G. Stiegler, D. Harris, T. C. VanCott, D. Hayes, M. K. Louder, C. R. Brown, C. V. Sapan, S. S. Frankel, Y. Lu, M. L. Robb, H. Katinger, and D. L. Birx. 1999. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73:4009-4018.
37. Mascola, J. R., G. Stiegler, T. C. VanCott, H. Katinger, C. B. Carpenter, C. E. Hanson, H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
38. Miller, C. J., M. Genesca, K. Abel, D. Montefiori, D. Forthal, K. Bost, J. Li, D. Favre, and J. M. McCune. 2007. Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. J. Virol. 81:5024-5035.
39. mac239 replication. J. Virol. 77:2736-2740.
40. + T cell responses. J. Immunol. 180:350-360.
41. + T cells and NK cells in simian immunodeficiency virus-infected macaques. J. Virol. 79:4877-4885.
42. Muthumani, K., M. Bagarazzi, D. Conway, D. S. Hwang, K. Manson, R. Ciccarelli, Z. Israel, D. C. Montefiori, K. Ugen, N. Miller, J. Kim, J. Boyer, and D. B. Weiner. 2003. A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduces viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus macaques. Vaccine 21:629-637.
43. O'Connor, D. H., B. R. Mothe, J. T. Weinfurter, S. Fuenger, W. M. Rehrauer, P. Jing, R. R. Rudersdorf, M. E. Liebl, K. Krebs, J. Vasquez, E. Dodds, J. Loffredo, S. Martin, A. B. McDermott, T. M. Allen, C. Wang, G. G. Doxiadis, D. C. Montefiori, A. Hughes, D. R. Burton, D. B. Allison, S. M. Wolinsky, R. Bontrop, L. J. Picker, and D. I. Watkins. 2003. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol. 77:9029-9040.
44. Oh, S., J. A. Berzofsky, D. S. Burke, T. A. Waldmann, and L. P. Perera. 2003. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc. Natl. Acad. Sci. USA 100:3392-3397.
45. Park, C. S., S. O. Yoon, R. J. Armitage, and Y. S. Choi. 2004. Follicular dendritic cells produce IL-15 that enhances germinal center B cell proliferation in membrane-bound form. J. Immunol. 173:6676-6683.
46. Parren, P. W., P. A. Marx, A. J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J. P. Moore, and D. R. Burton. 2001. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:8340-8347.
47. 89.6P challenge in Mamu-A01 negative rhesus macaques. Virology 374:322-337.
48. Patterson, L. J., N. Malkevitch, J. Pinczewski, D. Venzon, Y. Lou, B. Peng, C. Munch, M. Leonard, E. Richardson, K. Aldrich, V. S. Kalyanaraman, G. N. Pavlakis, and M. Robert-Guroff. 2003. Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120. J. Virol. 77:8607-8620.
49. mac251 challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting. J. Virol. 78:2212-2221.
50. Peng, B., L. R. Wang, V. R. Gomez-Roman, A. Davis-Warren, D. C. Montefiori, V. S. Kalyanaraman, D. Venzon, J. Zhao, E. Kan, T. J. Rowell, K. K. Murthy, I. Srivastava, S. W. Barnett, and M. Robert-Guroff. 2005. Replicating rather than nonreplicating adenovirus-human immunodeficiency virus recombinant vaccines are better at eliciting potent cellular immunity and priming high-titer antibodies. J. Virol. 79:10200-10209.
51. + memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200:1299-1314.
52. Picker, L. J., E. F. Reed-Inderbitzin, S. I. Hagen, J. B. Edgar, S. G. Hansen, A. Legasse, S. Planer, M. Piatak, Jr., J. D. Lifson, V. C. Maino, M. K. Axthelm, and F. Villinger. 2006. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J. Clin. Investig. 116:1514-1524.
53. Riechman, S. E., G. Balasekaran, S. M. Roth, and R. E. Ferrell. 2004. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J. Appl. Physiol. 97:2214-2219.
54. Robinson, T. M., M. K. Sidhu, G. N. Pavlakis, B. K. Felber, P. Silvera, M. G. Lewis, J. Eldridge, D. B. Weiner, and J. D. Boyer. 2007. Macaques coimmunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. J. Med. Primatol. 36:276-284.
55. Romano, J. W., R. N. Shurtliff, E. Dobratz, A. Gibson, K. Hickman, P. D. Markham, and R. Pal. 2000. Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology. J. Virol. Methods 86:61-70.
56. Sato, N., H. J. Patel, T. A. Waldmann, and Y. Tagaya. 2007. The IL-15/IL-15Rα on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells. Proc. Natl. Acad. Sci. USA 104:588-593.
57. Schadeck, E. B., M. Sidhu, M. A. Egan, S. Y. Chong, P. Piacente, A. Masood, D. Garcia-Hand, S. Cappello, V. Roopchand, S. Megati, J. Quiroz, J. D. Boyer, B. K. Felber, G. N. Pavlakis, D. B. Weiner, J. H. Eldridge, and Z. R. Israel. 2006. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine 24:4677-4687.
58. + lymphocytes. Science 283:857-860.
59. Shiver, J. W., T. M. Fu, L. Chen, D. R. Casimiro, M. E. Davies, R. K. Evans, Z. Q. Zhang, A. J. Simon, W. L. Trigona, S. A. Dubey, L. Huang, V. A. Harris, R. S. Long, X. Liang, L. Handt, W. A. Schleif, L. Zhu, D. C. Freed, N. V. Persaud, L. Guan, K. S. Punt, A. Tang, M. Chen, K. A. Wilson, K. B. Collins, G. J. Heidecker, V. R. Fernandez, H. C. Perry, J. G. Joyce, K. M. Grimm, J. C. Cook, P. M. Keller, D. S. Kresock, H. Mach, R. D. Troutman, L. A. Isopi, D. M. Williams, Z. Xu, K. E. Bohannon, D. B. Volkin, D. C. Montefiori, A. Miura, G. R. Krivulka, M. A. Lifton, M. J. Kuroda, J. E. Schmitz, N. L. Letvin, M. J. Caulfield, A. J. Bett, R. Youil, D. C. Kaslow, and E. A. Emini. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335.
60. Suh, Y. S., K. S. Park, U. Sauermann, M. Franz, S. Norley, D. Wilfingseder, H. Stoiber, Z. Fagrouch, J. Heeney, G. Hunsmann, C. Stahl-Hennig, and Y. C. Sung. 2006. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Vaccine 24:1811-1820.
61. van der Meide, P. H., F. Villinger, A. A. Ansari, R. J. Groenestein, M. C. de Labie, Y. J. van den Hout, W. H. Koornstra, W. M. Bogers, and J. L. Heeney. 2002. Stimulation of both humoral and cellular immune responses to HIV-1 gp120 by interleukin-12 in rhesus macaques. Vaccine 20:2296-2302.
62. Villinger, F., R. Miller, K. Mori, A. E. Mayne, P. Bostik, J. B. Sundstrom, C. Sugimoto, and A. A. Ansari. 2004. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine 22:3510-3521.
63. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6:595-601.
64. Zhao, J., Y. Lou, J. Pinczewski, N. Malkevitch, K. Aldrich, V. S. Kalyanaraman, D. Venzon, B. Peng, L. J. Patterson, Y. Edghill-Smith, R. Woodward, G. N. Pavlakis, and M. Robert-Guroff. 2003. Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants. Vaccine 21:4022-4035.
65. mac251. Vaccine 25:8021-8035.